Cedar Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-91,441
Closed -$1.69M 195
2024
Q4
$1.69M Buy
+91,441
New +$1.76M 0.61% 19
2024
Q3
Sell
-58,914
Closed -$1.16M 268
2024
Q2
$1.16M Hold
58,914
0.38% 38
2024
Q1
$1.06M Sell
58,914
-150
-0.3% -$2.72K 0.35% 38
2023
Q4
$1M Buy
59,064
+18,047
+44% +$359K 0.36% 37
2023
Q3
$815K Buy
41,017
+19,987
+95% +$379K 0.32% 43
2023
Q2
$395K Buy
+21,030
New +$424K 0.15% 72

Other funds holding BTAL

Cedar Wealth Management's BTAL Position: Q1 2025 in Review

Cedar Wealth Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q1 2025, closing a stake of 91,441 shares — an estimated $1.69M sold.

Cedar Wealth Management first reported a position in BTAL in Q2 2023 and held it in 6 quarters. The position peaked at $1.69M in Q4 2024. 71 funds tracked by Wall St. Rank hold BTAL as of Q1 2025.

  • Cedar Wealth Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q1 2025 after selling out during the quarter.
  • Cedar Wealth Management sold 91,441 AGF US Market Neutral Anti-Beta Fund shares in Q1 2025, an estimated $1.69M.
  • Cedar Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2023 and held it in 6 quarters.
  • Cedar Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $1.69M in Q4 2024.
  • 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2025.

Based on Cedar Wealth Management's 13F filing for Q1 2025, filed 9 May 2025.